⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3030006 | 0.63 | — | — | |
| SCHEMBL2825402 | 0.60 | — | — | |
| SCHEMBL18583040 | 0.60 | — | — | |
| SCHEMBL7714929 | 0.55 | — | — | |
| SCHEMBL7617769 | 0.55 | — | — | |
| SCHEMBL23721699 | 0.55 | — | — | |
| SCHEMBL5133363 | 0.55 | — | — | |
| SCHEMBL3818637 | 0.55 | — | — | |
| SCHEMBL4330924 | 0.55 | — | — | |
| SCHEMBL1418382 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 449 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024120442-A1 | PAK4 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | CONVERGEN (SUZHOU) PHARMACEUTICAL CO., LTD. (CN) | 2024-06-13 | — | — | WO | claimed |
| EP-3919496-A1 | POLYCYCLIC COMPOUND INHIBITING MNK1 AND MNK2 | Novostar Pharmaceuticals, Ltd. (CN) | 2021-12-08 | — | — | EP | claimed |
| EP-1480944-B1 | SUBSTITUTED ARYL KETONES | BAYER IP GMBH (DE) | 2016-08-10 | — | — | EP | claimed |
| US-7807703-B2 | Herbicides; pesticides | BAYER CROPSCIENCE AG (DE) | 2010-10-05 | — | — | US | claimed |
| US-20050153958-A1 | SUBSTITUTED ARYL KETONES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2005-07-14 | — | — | US | claimed |
| US-20050090397-A1 | Herbicides made from substituted aryl ketones | BAYER CROPSCIENCE AG (GB) | 2005-04-28 | — | — | US | claimed |
| US-5633253-A | TREATMENT OF DISEASES OF RHEUMATOID GENESIS | CIBY-GEIGY CORPORATION (US) | 1997-05-27 | — | — | US | claimed |
| EP-0211598-B1 | Pesticidal compounds | WELLCOME FOUND (GB) | 1993-12-15 | — | — | EP | claimed |
| CN-118339156-A | 2-Diazo-3-oxo-2, 3-dihydrospiro [ indene-1, 9' -xanthene ] derivatives and similar compounds as photoactive fluorescent compounds for protein labelling | 爱康治疗公司 | 2024-07-12 | — | — | CN | disclosed |
| US-20240199553-A1 | DIFLUOROMETHYLATION REACTION OF HETEROCYCLIC RING USING TETRAFLUOROETHYLENE | AGC Inc. (JP) | 2024-06-20 | — | — | US | disclosed |
| US-20240197888-A1 | SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | BIOTHERYX, INC. | 2024-06-20 | — | — | US | disclosed |
| EP-4385977-A1 | DIFLUOROMETHYLATION REACTION OF HETEROCYCLIC RING USING TETRAFLUOROETHYLENE | AGC INC. (JP) | 2024-06-19 | — | — | EP | disclosed |
| WO-2024120466-A1 | MONOSACCARIDES, PHARMACEUTICAL COMPOSITIONS, AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | SURIO THERAPEUTICS CO., LTD (CN) | 2024-06-13 | — | — | WO | disclosed |
| WO-2024120442-A1 | PAK4 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | CONVERGEN (SUZHOU) PHARMACEUTICAL CO., LTD. (CN) | 2024-06-13 | — | — | WO | disclosed |
| EP-0332387-B1 | Triazole derivatives, their preparation and their use as fungicides | SANKYO CO (JP) | 1993-11-24 | — | — | EP | disclosed |
| EP-0507863-A4 | SIGMA RECEPTOR LIGANDS AND THE USE THEREOF | — | 1993-07-07 | — | — | EP | disclosed |
| US-5211737-A | Herbicides and safeners | BASF AKTIENGESELLSCHAFT (DE) | 1993-05-18 | — | — | US | disclosed |
| EP-0507863-A1 | SIGMA RECEPTOR LIGANDS AND THE USE THEREOF | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 1992-10-14 | — | — | EP | disclosed |
| US-4999352-A | Antidepressants or fungicides | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-03-12 | — | — | US | disclosed |
| EP-0332387-A1 | Triazole derivatives, their preparation and their use as fungicides | Sankyo Company Limited (JP) | 1989-09-13 | — | — | EP | disclosed |